FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:CASP8-ALS2CR12 (FusionGDB2 ID:13284)

Fusion Gene Summary for CASP8-ALS2CR12

check button Fusion gene summary
Fusion gene informationFusion gene name: CASP8-ALS2CR12
Fusion gene ID: 13284
HgeneTgene
Gene symbol

CASP8

ALS2CR12

Gene ID

841

130540

Gene namecaspase 8flagellum associated containing coiled-coil domains 1
SynonymsALPS2B|CAP4|Casp-8|FLICE|MACH|MCH5ALS2CR12
Cytomap

2q33.1

2q33.1

Type of geneprotein-codingprotein-coding
Descriptioncaspase-8FADD-homologous ICE/CED-3-like proteaseFADD-like ICEICE-like apoptotic protease 5MACH-alpha-1/2/3 proteinMACH-beta-1/2/3/4 proteinMORT1-associated ced-3 homologapoptotic cysteine proteaseapoptotic protease Mch-5caspase 8, apoptosis-relatflagellum-associated coiled-coil domain-containing protein 1ALS2 chromosome region 12amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 proteinamyotrophic late
Modification date2020032220200313
UniProtAcc

Q14790

.
Ensembl transtripts involved in fusion geneENST00000392259, ENST00000392266, 
ENST00000264274, ENST00000432109, 
ENST00000264275, ENST00000392258, 
ENST00000490682, ENST00000358485, 
ENST00000323492, 
ENST00000286190, 
ENST00000405148, ENST00000392257, 
ENST00000439709, ENST00000448967, 
Fusion gene scores* DoF score10 X 7 X 10=7006 X 4 X 4=96
# samples 128
** MAII scorelog2(12/700*10)=-2.54432051622381
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(8/96*10)=-0.263034405833794
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: CASP8 [Title/Abstract] AND ALS2CR12 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointCASP8(202131514)-ALS2CR12(202195556), # samples:3
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneCASP8

GO:0006508

proteolysis

12888622

HgeneCASP8

GO:0036462

TRAIL-activated apoptotic signaling pathway

21785459

HgeneCASP8

GO:0045862

positive regulation of proteolysis

18387192

HgeneCASP8

GO:0097191

extrinsic apoptotic signaling pathway

21785459

HgeneCASP8

GO:0097202

activation of cysteine-type endopeptidase activity

18387192


check buttonFusion gene breakpoints across CASP8 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonFusion gene breakpoints across ALS2CR12 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4BRCATCGA-BH-A18T-01ACASP8chr2

202131514

+ALS2CR12chr2

202195556

-
ChimerDB4BRCATCGA-BH-A18T-01ACASP8chr2

202131514

+ALS2CR12chr2

202195556

-
ChimerDB4BRCATCGA-BH-A18T-01ACASP8chr2

202131514

-ALS2CR12chr2

202195556

-


Top

Fusion Gene ORF analysis for CASP8-ALS2CR12

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
In-frameENST00000392259ENST00000286190CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392259ENST00000405148CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392259ENST00000392257CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392259ENST00000439709CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
5CDS-intronENST00000392259ENST00000448967CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392266ENST00000286190CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392266ENST00000405148CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392266ENST00000392257CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392266ENST00000439709CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
5CDS-intronENST00000392266ENST00000448967CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000264274ENST00000286190CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000264274ENST00000405148CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000264274ENST00000392257CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000264274ENST00000439709CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
5CDS-intronENST00000264274ENST00000448967CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000432109ENST00000286190CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000432109ENST00000405148CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000432109ENST00000392257CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000432109ENST00000439709CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
5CDS-intronENST00000432109ENST00000448967CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000264275ENST00000286190CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000264275ENST00000405148CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000264275ENST00000392257CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000264275ENST00000439709CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
5CDS-intronENST00000264275ENST00000448967CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392258ENST00000286190CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392258ENST00000405148CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392258ENST00000392257CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000392258ENST00000439709CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
5CDS-intronENST00000392258ENST00000448967CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
intron-3CDSENST00000490682ENST00000286190CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
intron-3CDSENST00000490682ENST00000405148CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
intron-3CDSENST00000490682ENST00000392257CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
intron-3CDSENST00000490682ENST00000439709CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
intron-intronENST00000490682ENST00000448967CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000358485ENST00000286190CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000358485ENST00000405148CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000358485ENST00000392257CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000358485ENST00000439709CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
5CDS-intronENST00000358485ENST00000448967CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000323492ENST00000286190CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000323492ENST00000405148CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000323492ENST00000392257CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
In-frameENST00000323492ENST00000439709CASP8chr2

202131514

+ALS2CR12chr2

202195556

-
5CDS-intronENST00000323492ENST00000448967CASP8chr2

202131514

+ALS2CR12chr2

202195556

-

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for CASP8-ALS2CR12


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for CASP8-ALS2CR12


check button Go to

FGviewer for the breakpoints of chr2:202131514-chr2:202195556

.
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
CASP8

Q14790

.
FUNCTION: Thiol protease that plays a key role in programmed cell death by acting as a molecular switch for apoptosis, necroptosis and pyroptosis, and is required to prevent tissue damage during embryonic development and adulthood (By similarity). Initiator protease that induces extrinsic apoptosis by mediating cleavage and activation of effector caspases responsible for the TNFRSF6/FAS mediated and TNFRSF1A induced cell death (PubMed:23516580, PubMed:8681376, PubMed:8681377, PubMed:9006941, PubMed:9184224, PubMed:8962078). Cleaves and activates effector caspases CASP3, CASP4, CASP6, CASP7, CASP9 and CASP10 (PubMed:8962078, PubMed:9006941). Binding to the adapter molecule FADD recruits it to either receptor TNFRSF6/FAS mediated or TNFRSF1A (PubMed:8681376, PubMed:8681377). The resulting aggregate called death-inducing signaling complex (DISC) performs CASP8 proteolytic activation (PubMed:9184224). The active dimeric enzyme is then liberated from the DISC and free to activate downstream apoptotic proteases (PubMed:9184224). Proteolytic fragments of the N-terminal propeptide (termed CAP3, CAP5 and CAP6) are likely retained in the DISC (PubMed:9184224). In addition to extrinsic apoptosis, also acts as a negative regulator of necroptosis: acts by cleaving RIPK1 at 'Asp-324', which is crucial to inhibit RIPK1 kinase activity, limiting TNF-induced apoptosis, necroptosis and inflammatory response (PubMed:31827280, PubMed:31827281). Also able to initiate pyroptosis by mediating cleavage and activation of gasdermin-D (GSDMD): GSDMD cleavage promoting release of the N-terminal moiety (Gasdermin-D, N-terminal) that binds to membranes and forms pores, triggering pyroptosis (By similarity). Initiates pyroptosis following inactivation of MAP3K7/TAK1 (By similarity). Also acts as a regulator of innate immunity by mediating cleavage and inactivation of N4BP1 downstream of TLR3 or TLR4, thereby promoting cytokine production (By similarity). May participate in the Granzyme B (GZMB) cell death pathways (PubMed:8755496). Cleaves PARP1 (PubMed:8681376). {ECO:0000250|UniProtKB:O89110, ECO:0000269|PubMed:23516580, ECO:0000269|PubMed:31827280, ECO:0000269|PubMed:31827281, ECO:0000269|PubMed:8681376, ECO:0000269|PubMed:8681377, ECO:0000269|PubMed:8755496, ECO:0000269|PubMed:8962078, ECO:0000269|PubMed:9006941, ECO:0000269|PubMed:9184224}.; FUNCTION: [Isoform 5]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex. {ECO:0000305|PubMed:8681376}.; FUNCTION: [Isoform 6]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex. {ECO:0000305|PubMed:8681376}.; FUNCTION: [Isoform 7]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex (Probable). Acts as an inhibitor of the caspase cascade (PubMed:12010809). {ECO:0000269|PubMed:12010809, ECO:0000305|PubMed:8681376}.; FUNCTION: [Isoform 8]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex. {ECO:0000305|PubMed:8681376}.FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneCASP8chr2:202131514chr2:202195556ENST00000264274+372_80101.66666666666667396.0DomainDED 1
HgeneCASP8chr2:202131514chr2:202195556ENST00000264275+3102_80101.66666666666667497.0DomainDED 1
HgeneCASP8chr2:202131514chr2:202195556ENST00000323492+282_80101.66666666666667465.0DomainDED 1
HgeneCASP8chr2:202131514chr2:202195556ENST00000358485+292_80160.66666666666666539.0DomainDED 1
HgeneCASP8chr2:202131514chr2:202195556ENST00000392258+382_80101.66666666666667224.66666666666666DomainDED 1
HgeneCASP8chr2:202131514chr2:202195556ENST00000392259+392_80101.66666666666667751.3333333333334DomainDED 1
HgeneCASP8chr2:202131514chr2:202195556ENST00000392266+382_80101.66666666666667736.3333333333334DomainDED 1
HgeneCASP8chr2:202131514chr2:202195556ENST00000432109+3102_80101.66666666666667480.0DomainDED 1
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000286190514283_315174.66666666666666446.0Coiled coilOntology_term=ECO:0000255
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000286190514387_414174.66666666666666446.0Coiled coilOntology_term=ECO:0000255
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000392257615283_315174.66666666666666423.0Coiled coilOntology_term=ECO:0000255
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000392257615387_414174.66666666666666423.0Coiled coilOntology_term=ECO:0000255
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000405148615283_315174.66666666666666446.0Coiled coilOntology_term=ECO:0000255
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000405148615387_414174.66666666666666446.0Coiled coilOntology_term=ECO:0000255
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000439709615283_315174.66666666666666423.0Coiled coilOntology_term=ECO:0000255
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000439709615387_414174.66666666666666423.0Coiled coilOntology_term=ECO:0000255

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneCASP8chr2:202131514chr2:202195556ENST00000264274+37100_177101.66666666666667396.0DomainDED 2
HgeneCASP8chr2:202131514chr2:202195556ENST00000264275+310100_177101.66666666666667497.0DomainDED 2
HgeneCASP8chr2:202131514chr2:202195556ENST00000323492+28100_177101.66666666666667465.0DomainDED 2
HgeneCASP8chr2:202131514chr2:202195556ENST00000358485+29100_177160.66666666666666539.0DomainDED 2
HgeneCASP8chr2:202131514chr2:202195556ENST00000392258+38100_177101.66666666666667224.66666666666666DomainDED 2
HgeneCASP8chr2:202131514chr2:202195556ENST00000392259+39100_177101.66666666666667751.3333333333334DomainDED 2
HgeneCASP8chr2:202131514chr2:202195556ENST00000392266+38100_177101.66666666666667736.3333333333334DomainDED 2
HgeneCASP8chr2:202131514chr2:202195556ENST00000432109+310100_177101.66666666666667480.0DomainDED 2
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000286190514122_226174.66666666666666446.0Coiled coilOntology_term=ECO:0000255
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000392257615122_226174.66666666666666423.0Coiled coilOntology_term=ECO:0000255
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000405148615122_226174.66666666666666446.0Coiled coilOntology_term=ECO:0000255
TgeneALS2CR12chr2:202131514chr2:202195556ENST00000439709615122_226174.66666666666666423.0Coiled coilOntology_term=ECO:0000255


Top

Fusion Gene Sequence for CASP8-ALS2CR12


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for CASP8-ALS2CR12


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for CASP8-ALS2CR12


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

Related Diseases for CASP8-ALS2CR12


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneCASP8C0006142Malignant neoplasm of breast4CGI;CTD_human
HgeneCASP8C0678222Breast Carcinoma4CGI;CTD_human
HgeneCASP8C1257931Mammary Neoplasms, Human4CTD_human
HgeneCASP8C1458155Mammary Neoplasms4CTD_human
HgeneCASP8C4704874Mammary Carcinoma, Human4CTD_human
HgeneCASP8C1846545Autoimmune Lymphoproliferative Syndrome Type 2B3CTD_human;ORPHANET;UNIPROT
HgeneCASP8C0014859Esophageal Neoplasms2CTD_human
HgeneCASP8C0025202melanoma2CTD_human
HgeneCASP8C0546837Malignant neoplasm of esophagus2CTD_human
HgeneCASP8C0001418Adenocarcinoma1CTD_human
HgeneCASP8C0005586Bipolar Disorder1PSYGENET
HgeneCASP8C0007114Malignant neoplasm of skin1CTD_human
HgeneCASP8C0007131Non-Small Cell Lung Carcinoma1CTD_human
HgeneCASP8C0007873Uterine Cervical Neoplasm1CTD_human
HgeneCASP8C0009402Colorectal Carcinoma1CTD_human
HgeneCASP8C0009404Colorectal Neoplasms1CTD_human
HgeneCASP8C0011616Contact Dermatitis1CTD_human
HgeneCASP8C0011860Diabetes Mellitus, Non-Insulin-Dependent1CTD_human
HgeneCASP8C0013604Edema1CTD_human
HgeneCASP8C0023452Childhood Acute Lymphoblastic Leukemia1CTD_human
HgeneCASP8C0023453L2 Acute Lymphoblastic Leukemia1CTD_human
HgeneCASP8C0024121Lung Neoplasms1CTD_human
HgeneCASP8C0024623Malignant neoplasm of stomach1CTD_human
HgeneCASP8C0027055Myocardial Reperfusion Injury1CTD_human
HgeneCASP8C0035126Reperfusion Injury1CTD_human
HgeneCASP8C0037286Skin Neoplasms1CTD_human
HgeneCASP8C0038220Status Epilepticus1CTD_human
HgeneCASP8C0038356Stomach Neoplasms1CTD_human
HgeneCASP8C0151603Anasarca1CTD_human
HgeneCASP8C0162351Contact hypersensitivity1CTD_human
HgeneCASP8C0162820Dermatitis, Allergic Contact1CTD_human
HgeneCASP8C0205641Adenocarcinoma, Basal Cell1CTD_human
HgeneCASP8C0205642Adenocarcinoma, Oxyphilic1CTD_human
HgeneCASP8C0205643Carcinoma, Cribriform1CTD_human
HgeneCASP8C0205644Carcinoma, Granular Cell1CTD_human
HgeneCASP8C0205645Adenocarcinoma, Tubular1CTD_human
HgeneCASP8C0242379Malignant neoplasm of lung1CTD_human
HgeneCASP8C0270823Petit mal status1CTD_human
HgeneCASP8C0279607Adult Hepatocellular Carcinoma1ORPHANET
HgeneCASP8C0311335Grand Mal Status Epilepticus1CTD_human
HgeneCASP8C0343641Human papilloma virus infection1CTD_human
HgeneCASP8C0393734Complex Partial Status Epilepticus1CTD_human
HgeneCASP8C0751522Status Epilepticus, Subclinical1CTD_human
HgeneCASP8C0751523Non-Convulsive Status Epilepticus1CTD_human
HgeneCASP8C0751524Simple Partial Status Epilepticus1CTD_human
HgeneCASP8C1168401Squamous cell carcinoma of the head and neck1CTD_human
HgeneCASP8C1708349Hereditary Diffuse Gastric Cancer1CTD_human
HgeneCASP8C1961102Precursor Cell Lymphoblastic Leukemia Lymphoma1CTD_human
HgeneCASP8C2931456Prostate cancer, familial1CTD_human
HgeneCASP8C2937358Cerebral Hemorrhage1CTD_human
HgeneCASP8C4048328cervical cancer1CTD_human
HgeneCASP8C4722327PROSTATE CANCER, HEREDITARY, 11CTD_human